Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 05-oct-2026 · last seen 05-oct-2026

Epstein-Barr Virus Latency as a Stress Test of Aging Immune Surveillance

Current understanding

Lifelong EBV persistence in >90% of adults is reframed as a continuous functional probe of aging immune competence: age-related erosion of EBV-specific CD8 T-cell containment, NK surveillance, and tissue immune ecology permits reactivation, hyperinflammation, lymphoproliferation, and EBV-associated malignancy, with chronic active EBV disease and post-transplant lymphoproliferative disease sitting at the severe end of the spectrum [expert-opinion, review-level synthesis]. Mechanistic links to immunosenescence (CD8 exhaustion, inflationary memory, NK decline) and inflammaging (chronic antigenic drive, cytokine tone) are inferred from converging prior literature rather than new primary data. Human-translation status: the integrative framing is clinically grounded in known EBV syndromes but has not been operationalized into measurable ‘EBV immune-surveillance age’ metrics or interventions.

Evidence log

Open questions

Related

Contributing findings

pubmed review
Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.
30-sep-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18